Mandate

Vinge advises Trill Impact and ID North in connection with the acquisition of Pulsen Integration's IAM business

Vinge advises Trill Impact and its portfolio company ID North in connection with the acquisition of Pulsen Integration's Identity Access Management (IAM) business.

In total, 35 employees from Pulsen Integration in Sweden and Finland will become part of ID North, which operates within IAM and cyber security, providing IT consulting services, resale and in-house development of IT products with its base in Stockholm. At the same time, Pulsen Group becomes a shareholder in the parent company European ID Security, which includes ID North and Arctic Group. After the transaction, ID North consists of 65 employees in Sweden and Finland.

Vinge's team mainly consisted of Christina Kokko, Matthias Pannier, Samra Baytar, Nina Gransäter, Linus Adolfsson (M&A), Isabell Nielsen, Jolene Reimerson, Lisa Hörnqvist, Karolina Fuhrman (Commercial Agreements, IT & GDPR), Åsa Gotthardsson, Emil Lindwall (Employment), Arvid Axelryd (IP), Frida Ställborn (Real Property), Ulf Pyk (Banking and Finance), Ellinore Boström Andersson and Ellinor Gyllenhammar (Project Assistants).

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025